Opus Genetics, Inc (IRD) insider trading

Every open-market stock purchase and sale by Opus Genetics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $324K over the last 12 months (1 buy).
  • Insiders sold $16.4M over the last 12 months (12 sales).
  • Last insider buy: Cam Gallagher (Insider), $163K, 9 months ago.

Last 12 months: insiders bought $324K (1 buy) and sold $16.4M (12 sales). Last close $4.03 on Jun 4, 2026.

Recent IRD insider trades

DateInsiderTradeValue
May 18, 2026Foundation Fighting Blindness Retinal Degeneration Fund (Director)Sold$7.4M
Apr 23, 2026George Magrath (CEO)Sold$49.6K
Apr 23, 2026Robert E. Gagnon (CFO)Sold$40.7K
Apr 23, 2026Ashwath Jayagopal (Officer)Sold$39.2K
Apr 23, 2026Benjamin R Yerxa (President)Sold$39.1K
Apr 23, 2026Joseph K Schachle (COO)Sold$24.5K
Apr 23, 2026Rabourn Amy Zaremba (Insider)Sold$8.5K
Apr 20, 2026Susan Benton (Insider)Bought (not open market)—
Apr 20, 2026James S J Manuso (Insider)Bought (not open market)—
Apr 20, 2026Jean Bennett (Insider)Bought (not open market)—
Apr 20, 2026Richard J Rodgers (Insider)Bought (not open market)—
Apr 20, 2026Cam Gallagher (Insider)Bought (not open market)—
Apr 20, 2026Sean Ainsworth (Insider)Bought (not open market)—
Apr 20, 2026Adrienne L Graves (Insider)Bought (not open market)—
Mar 16, 2026George Magrath (CEO)Sold$127K
Mar 16, 2026Joseph K Schachle (COO)Sold$19.5K
Mar 16, 2026Ashwath Jayagopal (Officer)Sold$19K
Mar 16, 2026Rabourn Amy Zaremba (Insider)Sold$14.8K
Feb 12, 2026Ashwath Jayagopal (Officer)Sold (not open market)$18K
Jan 22, 2026Benjamin R Yerxa (President)Bought (not open market)—
Jan 22, 2026Robert E. Gagnon (CFO)Bought (not open market)—
Jan 22, 2026Ashwath Jayagopal (Officer)Bought (not open market)—
Jan 22, 2026Joseph K Schachle (COO)Bought (not open market)—
Jan 22, 2026George Magrath (CEO)Bought (not open market)—
Jan 22, 2026Rabourn Amy Zaremba (Insider)Bought (not open market)—

Who's trading IRD

Get free alerts when an insider at Opus Genetics, Inc files a new trade →